Cargando…
Authors' response: Comment on “clinicopathological features, survival outcomes, and appropriate surgical approaches for stage I acinar and papillary predominant lung adenocarcinoma”
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9089219/ https://www.ncbi.nlm.nih.gov/pubmed/35142110 http://dx.doi.org/10.1002/cam4.4585 |
| _version_ | 1784704474259914752 |
|---|---|
| author | Lu, Di Yang, Jianjun Liu, Xiguang Feng, Siyang Dong, Xiaoying Shi, Xiaoshun Zhai, Jianxue Mai, Shijie Jiang, Jianjun Wang, Zhizhi Wu, Hua Cai, Kaican |
| author_facet | Lu, Di Yang, Jianjun Liu, Xiguang Feng, Siyang Dong, Xiaoying Shi, Xiaoshun Zhai, Jianxue Mai, Shijie Jiang, Jianjun Wang, Zhizhi Wu, Hua Cai, Kaican |
| author_sort | Lu, Di |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9089219 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90892192022-05-16 Authors' response: Comment on “clinicopathological features, survival outcomes, and appropriate surgical approaches for stage I acinar and papillary predominant lung adenocarcinoma” Lu, Di Yang, Jianjun Liu, Xiguang Feng, Siyang Dong, Xiaoying Shi, Xiaoshun Zhai, Jianxue Mai, Shijie Jiang, Jianjun Wang, Zhizhi Wu, Hua Cai, Kaican Cancer Med Other John Wiley and Sons Inc. 2022-02-09 /pmc/articles/PMC9089219/ /pubmed/35142110 http://dx.doi.org/10.1002/cam4.4585 Text en © 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Other Lu, Di Yang, Jianjun Liu, Xiguang Feng, Siyang Dong, Xiaoying Shi, Xiaoshun Zhai, Jianxue Mai, Shijie Jiang, Jianjun Wang, Zhizhi Wu, Hua Cai, Kaican Authors' response: Comment on “clinicopathological features, survival outcomes, and appropriate surgical approaches for stage I acinar and papillary predominant lung adenocarcinoma” |
| title | Authors' response: Comment on “clinicopathological features, survival outcomes, and appropriate surgical approaches for stage I acinar and papillary predominant lung adenocarcinoma” |
| title_full | Authors' response: Comment on “clinicopathological features, survival outcomes, and appropriate surgical approaches for stage I acinar and papillary predominant lung adenocarcinoma” |
| title_fullStr | Authors' response: Comment on “clinicopathological features, survival outcomes, and appropriate surgical approaches for stage I acinar and papillary predominant lung adenocarcinoma” |
| title_full_unstemmed | Authors' response: Comment on “clinicopathological features, survival outcomes, and appropriate surgical approaches for stage I acinar and papillary predominant lung adenocarcinoma” |
| title_short | Authors' response: Comment on “clinicopathological features, survival outcomes, and appropriate surgical approaches for stage I acinar and papillary predominant lung adenocarcinoma” |
| title_sort | authors' response: comment on “clinicopathological features, survival outcomes, and appropriate surgical approaches for stage i acinar and papillary predominant lung adenocarcinoma” |
| topic | Other |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9089219/ https://www.ncbi.nlm.nih.gov/pubmed/35142110 http://dx.doi.org/10.1002/cam4.4585 |
| work_keys_str_mv | AT ludi authorsresponsecommentonclinicopathologicalfeaturessurvivaloutcomesandappropriatesurgicalapproachesforstageiacinarandpapillarypredominantlungadenocarcinoma AT yangjianjun authorsresponsecommentonclinicopathologicalfeaturessurvivaloutcomesandappropriatesurgicalapproachesforstageiacinarandpapillarypredominantlungadenocarcinoma AT liuxiguang authorsresponsecommentonclinicopathologicalfeaturessurvivaloutcomesandappropriatesurgicalapproachesforstageiacinarandpapillarypredominantlungadenocarcinoma AT fengsiyang authorsresponsecommentonclinicopathologicalfeaturessurvivaloutcomesandappropriatesurgicalapproachesforstageiacinarandpapillarypredominantlungadenocarcinoma AT dongxiaoying authorsresponsecommentonclinicopathologicalfeaturessurvivaloutcomesandappropriatesurgicalapproachesforstageiacinarandpapillarypredominantlungadenocarcinoma AT shixiaoshun authorsresponsecommentonclinicopathologicalfeaturessurvivaloutcomesandappropriatesurgicalapproachesforstageiacinarandpapillarypredominantlungadenocarcinoma AT zhaijianxue authorsresponsecommentonclinicopathologicalfeaturessurvivaloutcomesandappropriatesurgicalapproachesforstageiacinarandpapillarypredominantlungadenocarcinoma AT maishijie authorsresponsecommentonclinicopathologicalfeaturessurvivaloutcomesandappropriatesurgicalapproachesforstageiacinarandpapillarypredominantlungadenocarcinoma AT jiangjianjun authorsresponsecommentonclinicopathologicalfeaturessurvivaloutcomesandappropriatesurgicalapproachesforstageiacinarandpapillarypredominantlungadenocarcinoma AT wangzhizhi authorsresponsecommentonclinicopathologicalfeaturessurvivaloutcomesandappropriatesurgicalapproachesforstageiacinarandpapillarypredominantlungadenocarcinoma AT wuhua authorsresponsecommentonclinicopathologicalfeaturessurvivaloutcomesandappropriatesurgicalapproachesforstageiacinarandpapillarypredominantlungadenocarcinoma AT caikaican authorsresponsecommentonclinicopathologicalfeaturessurvivaloutcomesandappropriatesurgicalapproachesforstageiacinarandpapillarypredominantlungadenocarcinoma |